Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
8EP | Ann:Continuous Suspension from Official Quotation | 03/04/25 | 0 | 193 | |||
|
|||||||
8EP | Ann:Continuous Suspension from Official Quotation | 21/03/25 | 0 | 223 | |||
|
|||||||
8EP | Ann:Continued Suspension (Price Sensitive) | 16/09/24 | 0 | 358 | |||
|
|||||||
8EP | Ann:UPDATE ON ANNUAL REPORT LODGEMENT AND AGM (Price Sensitive) | 22/04/24 | 0 | 390 | |||
|
|||||||
8EP | Ann:Suspension from Official Quotation - Failure to lodge Annual Financial Statements for 31... | 04/04/24 | 0 | 413 | |||
|
|||||||
8EP | Ann:Trading Halt - Failure to lodge Annual Financial Statements for 31 December 2023 (Price... | 02/04/24 | 0 | 387 | |||
|
|||||||
8EP | Ann:Reinstatement to Official Quotation - Preliminary Final Report 31 December 2023 lodged (Price... | 19/03/24 | 0 | 437 | |||
|
|||||||
8EP | Ann:Preliminary Final Reporte YE (Price Sensitive) | 19/03/24 | 0 | 437 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||